Loading the company…
Loading the company…
In the last ten years FDA made 4 decisions for Aziyo Biologics (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2020 (1). The latest was on 2020-06-15.
| Family | Decisions on record |
|---|---|
| Hernia repair | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2020-06-15 | 510(k) | K201313 | CanGaroo Envelope (small), CanGaroo Envelope (medium), CanGaroo Envelope (large), CanGaroo Envelope (extra large), CanGaroo Enevlope (extra extra large) (SubQ) |
| 2019-10-21 | 510(k) | K192616 | CanGaroo Envelope (small), CanGaroo Envelope (medium), CanGaroo Envelope (large), CanGaroo Envelope (extra large), CanGaroo Envelope (extra extra large) (SubQ) |
| 2018-11-15 | 510(k) | K182255 | CanGaroo Neuro Envelope (small) ; CanGaroo Neuro Envelope (medium) ; CanGaroo Neuro Envelope (large) ; CanGaroo Neuro Envelope (extra large) |
| 2017-10-25 | 510(k) |
| K173242 |
| CanGaroo Envelope (small), CanGaroo Envelope (medium), CanGaroo Envelope (large), CanGaroo Envelope (extra large) |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Aziyo Biologics.